Vimarsana
Biggest News Aggregation in the World

Page 2 - Cell Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Sciences Today - Breaking & Trending Today

Global Immunoassay Market Report 2022-2027: Importance of Companion Diagnostics, Development of Condition-Specific Biomarkers and Tests, & Integration of Microfluidics in Immunoassays - Vimarsana News

Global Immunoassay Market Report 2022-2027: Importance of Companion Diagnostics, Development of Condition-Specific Biomarkers and Tests, & Integration of Microfluidics in Immunoassays

/PRNewswire/ -- The "Global Immunoassay Market by Product (Reagents & Kits, Analyzers), Technology (ELISA, Rapid Test, Western Blotting, ELISPOT), Specimen...

Global Immunoassay Market Growth Rate, Key Players, Demands, Size, Share, Specimen, Application and Forecasts to 2027 - Vimarsana News

Global Immunoassay Market Growth Rate, Key Players, Demands, Size, Share, Specimen, Application and Forecasts to 2027

PUNE, India, Aug. 30, 2022 /PRNewswire/ -- The global immunoassay market is valued at an estimated USD 40.2 billion in 2022 and is projected to reach USD 49.6 billion by 2027, at a CAGR of 4.3%

SARS-CoV-2 cytokine storm inhibited by curcumin nanoparticles - Vimarsana News

SARS-CoV-2 cytokine storm inhibited by curcumin nanoparticles

In a recent study published in the journal ACS Applied Bio Materials, researchers demonstrated the inhibitory potential of curcumin-encapsulated polysaccharide nanoparticles (CUR−PS-NPs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (CoV2-SP)-stimulated cytokine storm in lung and liver epithelial cells.

India Coronavirus Dispatch: Bihar worst performer on vaccination coverage - Vimarsana News

India Coronavirus Dispatch: Bihar worst performer on vaccination coverage

Read more about India Coronavirus Dispatch: Bihar worst performer on vaccination coverage on Business Standard. Delta variant now in 174 districts across the country, govt is developing two new testing labs for vaccines, more-news relevant to India's fight against the pandemic

Immunoassay Market by Product, Technology, Specimen Application and End-user - Vimarsana News

Immunoassay Market by Product, Technology, Specimen Application and End-user

Share this article Share this article ResearchAndMarkets.com's offering. The global immunoassay market is projected to reach USD 39.0 billion by 2026 from USD 28.4 billion in 2021, at a CAGR of 6.6% during the forecast period. Market growth is largely driven by the rising incidence of chronic and infectious diseases, technological advancements of immunoassay products, and their massive adoptions. Emerging markets in Asian countries are expected to offer strong growth opportunities for players in the market. In contrast, the stringent regulatory scenario and technical hurdles of the immunoass...